SANCHITA TRIPATHY

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (13)

• Toxicity Study of Therapeutically Active Copper Nitroprusside Analogue Nanoparticles: An In Vitro and In Vivo Approaches
  Chemical Research in Toxicology 2026 DOI: 10.1021/acs.chemrestox.6c00016
  +Save
• Eggshell-derived nanoparticles accelerate wound healing
  Journal of Materials Chemistry B 2026 DOI: 10.1039/D6TB00239K
  +Save
• Folic acid–encapsulated silver nitroprusside nanoparticles for targeted therapy in ovarian cancer
  Biomedical Materials 2025 DOI: 10.1088/1748-605X/add2b9
  +Save
• Esterase-induced release of a theranostic prodrug in lysosomes for improved therapeutic efficacy and lower systemic toxicity
  Chemical Science 2025 DOI: 10.1039/D5SC03783B
  +Save
• Therapeutic Potential of Silver Nitroprusside Nanoparticles for Melanoma
  ACS Applied Bio Materials 2024 DOI: 10.1021/acsabm.4c00597
  +Save
• Nitroprusside and metal nitroprusside nano analogues for cancer therapy
  Biomedical Materials 2024 DOI: 10.1088/1748-605X/ad2c18
  +Save
• Neuritogenic Activity of Metal Nanoparticles
  Nanomedicine 2024 DOI: 10.2217/nnm-2023-0297
  +Save
• Copper nitroprusside analogue nanoparticles against melanoma: detailed in vitro and in vivo investigation
  Nanoscale 2024 DOI: 10.1039/D4NR01857E
  +Save
• Design of Lysozyme‐Templated Biocompatible Fluorescent Nanocomposites and Their Potential Applications for Cell Imaging, Hydrogen Peroxide Sensing, and Cancer Therapy
  Advanced Therapeutics 2023 DOI: 10.1002/adtp.202200293
  +Save
• Silver nitroprusside nanoparticles for breast cancer therapy: in vitro and in vivo approach
  Nanoscale 2023 DOI: 10.1039/D3NR00221G
  +Save